3673
-
Pharmacogenomics and Personalized Medicine
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
Pharmacogenomics and Personalized Medicine
(41,732) Views
Editor in Chief Dr Martin H Bluth
1178-7066
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicinePeter Avery, Shaymaa S Mousa, Shaker A Mousa
The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent
Hector Clarke, Shaker A Mousa
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
Robert Greene, Shaymaa S Mousa, Mohamed Ardawi, et al
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
Christopher Barone, Shaymaa S Mousa, Shaker A Mousa
Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island
Thouraya Baroudi Ouederni, Ahmed Fadiel, Nejla Stambouli, et al
Genomics and proteomics: Applications in autoimmune diseases
Wolfgang Hueber, William H Robinson
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
Steven F Powell, Arkadiusz Z Dudek
Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis
Janet K Coller, Julia Beardsley, James Bignold, Yibai Li, Florence Merg, et al
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
Avery Schwartz, Shany Blum, Rabea Asleh, Mordechai Pollak, Shiri Kalet-Litman, Andrew P Levy
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
